Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Effects of cyp2c9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Bae, J. W.
  • Choi, C. I.
  • Jang, Choon-Gon
  • Lee, S. Y.

publication date

  • 2011

journal

  • British Journal of Clinical Pharmacology  Journal

subject areas

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal
  • Aryl Hydrocarbon Hydroxylases
  • Asian Continental Ancestry Group
  • Cyclooxygenase Inhibitors
  • Cytochrome P-450 CYP2C9
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Polymorphism, Genetic
  • Republic of Korea
  • Thiazines
  • Thiazoles
  • Young Adult
scroll to property group menus

Research

keywords

  • CYP2C9
  • genetic polymorphism
  • meloxicam
  • pharmacodynamics
  • pharmacokinetics
scroll to property group menus

Identity

PubMed Central ID

  • PMC3080643

International Standard Serial Number (ISSN)

  • 0306-5251

Digital Object Identifier (DOI)

  • 10.1111/j.1365-2125.2010.03853.x

PubMed ID

  • 21395648
scroll to property group menus

Additional Document Info

start page

  • 550

end page

  • 555

volume

  • 71

issue

  • 4

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support